The Effect of Physical Activity on The Response of Autonomic Nervous System in Individuals With Autism Spectrum Disorders of Different Age Groups

Sponsor
University of Jazan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05725733
Collaborator
(none)
200
2
6

Study Details

Study Description

Brief Summary

This study will investigate the effect of physical activity on autism spectrum disorder (ASD) in individuals with ASD of different age groups through measuring the hemodynamic, heart activity and respiratory system parameters.

Condition or Disease Intervention/Treatment Phase
  • Other: Physical Therapy
N/A

Detailed Description

One hundred participants will be included in this study. One hundred typically developed children or control group and one hundred children with ASD group. The age range of participants will be 4 - 18 years old. The participants in both control and ASD groups will be randomly divided into 4 subgroups according to their age (4-7 years old, 7-10 years old, 10-13 years old and, 14-18 years old). Also, ASD group will be categorized according to the symptoms severity using the childhood autism rating scale (CARS). Participants will be excluded if they have any intellectual disability (IQ ≤ 70), co-morbid medical or psychiatric disorders, pervasive developmental disorders (PDD) or Attention-deficit hyperactivity disorders (ADHD). They will also be excluded if they are taking any medications which to affect cardiovascular system, respiratory system, or arousal and balance or any other contraindications to exercises. Wechsler Intelligence Scale for Children-Fourth Edition24 will be used to assess the Intelligence Quotient (IQ).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A single- blinded randomized controlled study design will be used, the exercise program will be administrated for four weeks, three times per week, and sixteen minutes per session. Heart rate, ECG, Measurements of respiration, and blood pressure will be measured three times every session: at rest before starting exercises (baseline), directly after finishing exercises, and 15 minutes after finishing exercises.A single- blinded randomized controlled study design will be used, the exercise program will be administrated for four weeks, three times per week, and sixteen minutes per session. Heart rate, ECG, Measurements of respiration, and blood pressure will be measured three times every session: at rest before starting exercises (baseline), directly after finishing exercises, and 15 minutes after finishing exercises.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
The Effect of Physical Activity on The Response of Autonomic Nervous System in Individuals With Autism Spectrum Disorders of Different Age Groups
Anticipated Study Start Date :
Feb 12, 2023
Anticipated Primary Completion Date :
Jul 12, 2023
Anticipated Study Completion Date :
Aug 13, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: children with ASD group.

ASD groups will be randomly divided into 4 subgroups according to their age (4-7 years old, 7-10 years old, 10-13 years old and, 14-18 years old). Also, ASD group will be categorized according to the symptoms severity using the childhood autism rating scale (CARS).

Other: Physical Therapy
The participant will walk for 3-minutes at this speed as a warming up period. After these 3-minutes, the speed will be increased gradually up to 5-6 km/minute under the supervision of parents and therapist. The children will perform 10-minute running at this speed. After this, the cooling down exercise will be performed for 3-minutes. The speed will be decreased for 2 km/ minute and gradually stop.
Other Names:
  • Treadmill walking program
  • Active Comparator: One hundred typically developed children or control group

    They will be randomly divided into 4 subgroups according to their age (4-7 years old, 7-10 years old, 10-13 years old and, 14-18 years old)

    Other: Physical Therapy
    The participant will walk for 3-minutes at this speed as a warming up period. After these 3-minutes, the speed will be increased gradually up to 5-6 km/minute under the supervision of parents and therapist. The children will perform 10-minute running at this speed. After this, the cooling down exercise will be performed for 3-minutes. The speed will be decreased for 2 km/ minute and gradually stop.
    Other Names:
  • Treadmill walking program
  • Outcome Measures

    Primary Outcome Measures

    1. ECG measurements [One minute]

      A wearable device will be used to collet cardiac ECG data.

    2. Measurements of respiration [5 minutes]

      Portable Respiratory Monitor will be used to measure the respiratory activity.

    3. Blood pressure measurement [5 minutes]

      Manual sphygmomanometer will be used to measure the blood pressure.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Children with ASD group with the age range of participants will be 4 - 18 years old

    2. Typically developed children with the age range of participants will be 4 - 18 years old

    Exclusion Criteria:
    Participants will be excluded if they have the following:
    • any intellectual disability (IQ ≤ 70)

    • co-morbid medical or psychiatric disorders.

    • pervasive developmental disorders (PDD) or Attention-deficit hyperactivity disorders (ADHD).

    • They will also be excluded if they are taking any medications which to affect cardiovascular system, respiratory system, or arousal and balance or any other contraindications to exercises.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Jazan

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohammed Moustafa, Assistant Professor, University of Jazan
    ClinicalTrials.gov Identifier:
    NCT05725733
    Other Study ID Numbers:
    • 2265749561
    First Posted:
    Feb 13, 2023
    Last Update Posted:
    Feb 13, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 13, 2023